Related Articles
Influence of CYP2C19 genotype on antiplatelet treatment outcomes after percutaneous coronary intervention in patients with coronary heart disease
Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention
Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention
The value of Sonoclot detection technology to guide the clinical medication of the perioperative anticoagulation and antiplatelet therapy in patients with acute myocardial infarction undergoing emergent PCI
Allele frequency distribution of CYP2C19*2 allelic variants associated with clopidogrel resistance in cardiac patients